Changing the paradigm for first-line treatment may result in healthier, happier patients.
Noecker
R J
RJ
University of Arizona, Tuscon, USA.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D003663:Decision Trees; D005901:Glaucoma / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D009885:Ophthalmology / Q000379:methods; D017060:Patient Satisfaction; D018579:Patient Selection
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors